|
English
|
正體中文
|
简体中文
|
总笔数 :0
|
|
造访人次 :
51037197
在线人数 :
963
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"john t"的相关文件
显示项目 26-29 / 29 (共2页)
<< < 1 2
每页显示[10|25|50]项目
| 國立成功大學 |
2018 |
EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer
|
John, T.;Akamatsu, H.;Delmonte, A.;Su, W.-C.;Lee, J.S.;Chang, G.-C.;Huang, X.;Jenkins, S.;Wu, Y.-L. |
| 臺大學術典藏 |
2017 |
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study
|
Ahn M.-J; Kim D.-W; Cho B.C; Kim S.-W; Lee J.S; Ahn J.-S; Kim T.M; Lin C.-C; Kim H.R; John T; Kao S; Goldman J.W; Su W.-C; Natale R; Rabbie S; Harrop B; Overend P; Yang Z; CHIH-HSIN YANG; Chih-Hsin Yang;Yang Z;Overend P;Harrop B;Rabbie S;Natale R;Su W.-C;Goldman J.W;Kao S;John T;Kim H.R;Lin C.-C;Kim T.M;Ahn J.-S;Lee J.S;Kim S.-W;Cho B.C;Kim D.-W;Ahn M.-J |
| 臺大學術典藏 |
2017 |
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study
|
Ahn M.-J; Kim D.-W; Cho B.C; Kim S.-W; Lee J.S; Ahn J.-S; Kim T.M; Lin C.-C; Kim H.R; John T; Kao S; Goldman J.W; Su W.-C; Natale R; Rabbie S; Harrop B; Overend P; Yang Z; CHIH-HSIN YANG; Chih-Hsin Yang;Yang Z;Overend P;Harrop B;Rabbie S;Natale R;Su W.-C;Goldman J.W;Kao S;John T;Kim H.R;Lin C.-C;Kim T.M;Ahn J.-S;Lee J.S;Kim S.-W;Cho B.C;Kim D.-W;Ahn M.-J |
| 國立成功大學 |
2017 |
Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study
|
Ahn, M.-J.;Kim, D.-W.;Cho, B.C.;Kim, S.-W.;Lee, J.S.;Ahn, J.-S.;Kim, T.M.;Lin, C.-C.;Kim, H.R.;John, T.;Kao, S.;Goldman, J.W.;Su, W.-C.;Natale, R.;Rabbie, S.;Harrop, B.;Overend, P.;Yang, Z.;Yang, J.C.-H. |
显示项目 26-29 / 29 (共2页)
<< < 1 2
每页显示[10|25|50]项目
|
